SSG
TWST icon

Summit Securities Group’s Twist Bioscience TWST Stock Holding History

Summit Securities Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-122
Closed -$4.79K – 1438
2025
Q1 		$4.79K Buy
+122
New +$5.5K ﹤0.01% 609
2024
Q4 		– Sell
-119
Closed -$5K – 901
2024
Q3 		$5K Buy
+119
New +$5.66K ﹤0.01% 428

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Summit Securities Group's TWST Position: Q2 2025 in Review

Summit Securities Group sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 122 shares — an estimated $4.79K sold.

Summit Securities Group first reported a position in TWST in Q3 2024 and held it in 2 quarters. The position peaked at $5K in Q3 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Summit Securities Group reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 122 Twist Bioscience shares in Q2 2025, an estimated $4.79K.
  • Summit Securities Group first reported a position in Twist Bioscience in Q3 2024 and held it in 2 quarters.
  • Summit Securities Group's Twist Bioscience position peaked at $5K in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.